Tumor necrosis factor-receptor 2 is upregulated on lamina propria mononuclear cells in Crohn's disease and promotes experimental colitis in vivo

被引：0
|
作者：
Holtmann, M
Douni, E
Schutz, M
Scheurich, P
Gerspach, J
Galle, PR
Kollias, G
Neurath, M
机构：
来源：
GASTROENTEROLOGY | 2002年 / 122卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
M1048
引用
收藏
页码：A259 / A260
页数：2
相关论文
共 50 条
  • [41] TUMOR NECROSIS FACTOR-ALPHA INHIBITORS INCREASED RISK OF MILD CERVICAL DYSPLASIA IN CROHN'S DISEASE, BUT NOT IN ULCERATIVE COLITIS
    Xie, Mengdan
    Deng, Lifu
    Song, Gengqing
    Landsman, Marc J.
    GASTROENTEROLOGY, 2024, 166 (05) : S506 - S506
  • [42] Tumor necrosis factor α promotes invasiveness of cholangiocarcinoma cells via its receptor, TNFR2
    Tanimura, Y
    Kokuryo, T
    Tsunoda, N
    Yamazaki, Y
    Oda, K
    Nimura, Y
    Mon, NN
    Huang, PY
    Nakanuma, Y
    Chen, MF
    Jan, YY
    Yeh, TS
    Chiu, CT
    Hsieh, LL
    Hamaguchi, M
    CANCER LETTERS, 2005, 219 (02) : 205 - 213
  • [43] Chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn's disease -: Reply
    Targan, SR
    Schaible, TF
    NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (05): : 334 - 334
  • [44] Lack of TNF receptor down-regulation on lamina propria macrophages and T-cells dispite increased TNFA levels in Crohn's disease.
    Holtmann, MH
    Schuetz, M
    Grell, M
    Galle, PR
    Neurath, MF
    GASTROENTEROLOGY, 2000, 118 (04) : A1125 - A1125
  • [45] Tumor Necrosis Factor Receptor 2 Restricts the Pathogenicity of CD8+ T Cells in Mice With Colitis
    Punit, Shivesh
    Dube, Philip E.
    Liu, Cambrian Y.
    Girish, Nandini
    Washington, M. Kay
    Polk, D. Brent
    GASTROENTEROLOGY, 2015, 149 (04) : 993 - U716
  • [46] Association between polymorphism of tumor necrosis factor receptor 1A and diminished bone density in Crohn's disease
    Theal, JJ
    Silverberg, M
    Steinhart, H
    Irwin, S
    Greenberg, GR
    GASTROENTEROLOGY, 2004, 126 (04) : A353 - A353
  • [47] Lamina propria T cells in Crohn's disease and other gastrointestinal inflammation show defective CD2 pathway-induced apoptosis
    Boirivant, M
    Marini, M
    Di Felice, G
    Pronio, AM
    Montesani, C
    Tersigni, R
    Strober, W
    GASTROENTEROLOGY, 1999, 116 (03) : 557 - 565
  • [48] Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis on the use of anti-tumor necrosis factor drugs in inflammatory bowel disease
    Luis Cabriada, Jose
    Vera, Isabel
    Domenech, Eugeni
    Barreiro-de Acosta, Manuel
    Esteve, Maria
    Gisbert, Javier P.
    Panes, Julia
    Gomollon, Fernando
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2013, 36 (03): : 127 - 146
  • [49] Requirement for tumor necrosis factor receptor 2 expression on vascular cells to induce experimental cerebral malaria
    Stoelcker, B
    Hehlgans, T
    Weigl, K
    Bluethmann, H
    Grau, GE
    Männel, DN
    INFECTION AND IMMUNITY, 2002, 70 (10) : 5857 - 5859
  • [50] CROHN'S DISEASE PATIENTS WITH USTEKINUMAB-INDUCED REMISSION ARE CHARACTERIZED BY HIGH BASELINE IL23 RECEPTOR EXPRESSION IN THE LAMINA PROPRIA TH1 CELLS
    Onali, S.
    Di, Petrillo A.
    Favale, A.
    Carpineti, C.
    Cadoni, M.
    Loddo, E.
    Fantini, M. C.
    DIGESTIVE AND LIVER DISEASE, 2023, 55 : S159 - S159
12345